CoChat

Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis

Open access

Published version of a preprint

The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.

Abstract

Cytosolic DNA is characteristic of chromosomally unstable metastatic cancer cells, resulting in constitutive activation of the cGAS–STING innate immune pathway. How tumors co-opt inflammatory signaling while evading immune surveillance remains unknown. Here, we show that the ectonucleotidase ENPP1 promotes metastasis by selectively degrading extracellular cGAMP, an immune-stimulatory metabolite whose breakdown products include the immune suppressor adenosine. ENPP1 loss suppresses metastasis, restores tumor immune infiltration, and potentiates response to immune checkpoint blockade in a manner dependent on tumor cGAS and host STING. Conversely, overexpression of wild-type ENPP1, but not an enzymatically weakened mutant, promotes migration and metastasis, in part through the generation of extracellular adenosine, and renders otherwise sensitive tumors completely resistant to immunotherapy. In human cancers, ENPP1 expression correlates with reduced immune cell infiltration, increased metastasis, and resistance to anti–PD-1/PD-L1 treatment. Thus, cGAMP hydrolysis by ENPP1 enables chromosomally unstable tumors to transmute cGAS activation into an immune-suppressive pathway. Significance: Chromosomal instability promotes metastasis by generating chronic tumor inflammation. ENPP1 facilitates metastasis and enables tumor cells to tolerate inflammation by hydrolyzing the immunotransmitter cGAMP, preventing its transfer from cancer cells to immune cells. This article is highlighted in the In This Issue feature, p. 995

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-20-0387

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 312

Metadata

Authors
Li, J., Duran, M. A., Dhanota, N., Chatila, W. K., Bettigole, S. E., Kwon, J., Sriram, R. K., Humphries, M. P., Salto-Tellez, M., James, J. A., Hanna, M. G., Melms, J. C., Vallabhaneni, S., Litchfield, K., Usaite, I., Biswas, D., Bareja, R., Li, H. W., Martin, M. L., Dorsaint, P., Cavallo, J.-A., Li, P., Pauli, C., Gottesdiener, L., DiPardo, B. J., Hollmann, T. J., Merghoub, T., Wen, H. Y., Reis-Filho, J. S., Riaz, N., Su, S.-S. M., Kalbasi, A., Vasan, N., Powell, S. N., Wolchok, J. D., Elemento, O., Swanton, C., Shoushtari, A. N., Parkes, E. E., Izar, B., & Bakhoum, S. F.
Affiliations
  • Memorial Sloan Kettering Cancer Center (US)
  • 1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • 4Volastra Therapeutics Inc., New York, New York.
  • Weill Cornell Medicine (US)
  • Queen's University Belfast (GB)
  • 6Precision Medicine Centre of Excellence, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom.
  • Columbia University Irving Medical Center (US)
  • Harvard University (US)
  • The Francis Crick Institute (GB)
  • 9Columbia Center for Translational Immunology, New York, New York.
  • 13Englander Institute for Precision Medicine, Meyer Cancer Center, Weill Cornell Medicine, New York, New York.
  • 14Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • University Hospital Zurich (CH)
  • University of California, Los Angeles (US)
  • University of Oxford (GB)
Corresponding author
Bakhoum, Samuel F.
Venue
Cancer Discovery
Published
2020-12-28
Volume
11
Issue
5
Pages
1212-1227
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W3115597636
Cited by
312
References
47
Citations by year
2026: 53 · 2025: 58 · 2024: 71 · 2023: 61 · 2022: 47 · 2021: 22
FWCI
20.42
Type
journal article
Language
en
Open access
Locations
  • Cancer Discovery (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Research Portal (Queen's University Belfast) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • NIH (DP5OD026395, K08CA222663, U54CA225088)
  • NCI (P50CA247749)
  • MSKCC (P30-CA008748)
  • Burroughs Wellcome Fund Career Award for Medical Scientists Louis V. Gerstner Jr. Scholars Program Herbert Irving Comprehensive Cancer Center (P30CA013696)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Keywords
ENPP1, metastasis, immune evasion, cGAS-STING pathway, extracellular adenosine, chromosomal instability, tumor inflammation, immune checkpoint inhibitor resistance, PD-1/PD-L1 blockade, tumor immune infiltration, ectonucleotidases, tumor microenvironment
MeSH terms
Animals, Humans, Hydrolysis, Immunotherapy, Mice, Inbred BALB C, Neoplasm Metastasis, Neoplasms, Nucleotides, Cyclic, Tumor Escape, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.